Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Functional Consequences of the CTNS-deletion for the TRPV1-receptor in Cystinosis Patients

NCT02533076 is registered in ClinicalTrials.gov with Universitaire Ziekenhuizen KU Leuven as lead sponsor.

NCT NCT02533076
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02533076 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Functional Consequences of the CTNS-deletion for the TRPV1-receptor in Cystinosis Patients
Lead sponsor
Universitaire Ziekenhuizen KU Leuven
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2014
Completion date
July 31, 2015
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cystinosis